Disclosed are methods of inhibiting production of myeloid lineage hematologic cells through the administration of various members of the chemokine family. Chemokines useful for inhibiting myeloid cell production include MIP1 alpha, and beta, IL-8, PF4, and MCAF.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.